Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.
N Engl J Med. 2022 Apr 14;386(15):1475-1477. doi: 10.1056/NEJMc2201933. Epub 2022 Mar 9.
N Engl J Med. 2022.
PMID: 35263535
Free PMC article.
No abstract available.
Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2.
Sakai-Tagawa Y, Yamayoshi S, Halfmann PJ, Kawaoka Y.
Sakai-Tagawa Y, et al.
Viruses. 2021 Oct 29;13(11):2183. doi: 10.3390/v13112183.
Viruses. 2021.
PMID: 34834991
Free PMC article.
Item in Clipboard
Host glycolipids in SARS-CoV-2 entry.
Uraki R, Kawaoka Y.
Uraki R, et al.
Nat Chem Biol. 2022 Jan;18(1):6-7. doi: 10.1038/s41589-021-00923-2.
Nat Chem Biol. 2022.
PMID: 34754100
No abstract available.
Item in Clipboard
Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages.
Maemura T, Kuroda M, Armbrust T, Yamayoshi S, Halfmann PJ, Kawaoka Y.
Maemura T, et al.
mBio. 2021 Oct 26;12(5):e0198721. doi: 10.1128/mBio.01987-21. Epub 2021 Sep 28.
mBio. 2021.
PMID: 34579572
Free PMC article.
Item in Clipboard
Cite
Cite